Francesco Dazzi

Francesco Dazzi publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Francesco Dazzi sits on this spectrum.

Francesco Dazzi D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Francesco Dazzi sits on this spectrum.

Best Publications

• Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

  Mauro Krampera;Sarah Glennie;Julian Dyson;Diane Scott

  2231
  Citations

• Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells.

  Sarah Glennie;Inês Soeiro;Peter J. Dyson;Eric W.-F. Lam

  1563
  Citations

• Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation.

  Antonio Galleu;Yanira Riffo-Vasquez;Cristina Trento;Cara Lomas

  676
  Citations

• Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle.

  Rajesh Ramasamy;Henrietta Fazekasova;Eric W.-F. Lam;In s Soeiro

  621
  Citations

• Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth.

  R Ramasamy;E. W. F. Lam;I. Soeiro;Veronica Tisato

  553
  Citations

• International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials

  Jacques Galipeau;Mauro Krampera;John Barrett;Francesco Dazzi

  520
  Citations

• The role of mesenchymal stem cells in haemopoiesis.

  Francesco Dazzi;Rajesh Ramasamy;Sarah Glennie;Simon P. Jones

  509
  Citations

• Mesenchymal stem cells: the fibroblasts' new clothes?

  Muzlifah A. Haniffa;Matthew P. Collin;Christopher D. Buckley;Francesco Dazzi

  457
  Citations

• Characterization and Clinical Application of Human CD34+ Stem/Progenitor Cell Populations Mobilized into the Blood by Granulocyte Colony-Stimulating Factor

  Myrtle Y. Gordon;Nataša Levičar;Madhava Pai;Philippe Bachellier

  422
  Citations

• European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor.

  David Marin;Dragana Milojkovic;Eduardo Olavarria;Jamshid S. Khorashad

  415
  Citations

• Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia

  Francesco Dazzi;R. M. Szydlo;C. Craddock;N. C. Cross

  407
  Citations

• Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

  T. Ruutu;A. Gratwohl;T. De Witte;B. Afanasyev

  394
  Citations

• Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment.

  Francis Mussai;Carmela De Santo;Issa Abu-Dayyeh;Sarah Booth

  348
  Citations

• The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells.

  Simon Jones;Nicole Horwood;Andrew Cope;Francesco Dazzi

  324
  Citations

• Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia

  Francesco Dazzi;Richard M. Szydlo;Nicholas C P Cross;C. Charles Craddock

  322
  Citations

• The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function.

  Rajesh Ramasamy;Rajesh Ramasamy;Chih Kong Tong;Heng Fong Seow;Sharmili Vidyadaran

  291
  Citations

• HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation.

  Mauro Krampera;Mauro Krampera;Annalisa Pasini;Annalisa Pasini;Antonella Rigo;Antonella Rigo;Maria Teresa Scupoli;Maria Teresa Scupoli

  277
  Citations

• Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease.

  V. Tisato;K. Naresh;J. Girdlestone;C. Navarrete

  252
  Citations

• The immunosuppressive properties of mesenchymal stem cells.

  Georg Siegel;Richard Schäfer;Francesco Dazzi

  251
  Citations

• The immunomodulatory properties of mesenchymal stem cells

  Ilaria Marigo;Francesco Dazzi

  249
  Citations